Cell Thereapeutics, Inc. Corporate Headquarters
501 Elliott Avenue West, Suite 400
Seattle, WA 98119
T 206-282-7100
T 800-215-CELL (US)
F 206-284-6206
Cell Therapeutics, Inc. Sede Secondaria
Via Ariosto, 23
20091 Bresso (Milan) — Italy
T +39 02 61035.1
F +39 02 61035601
Systems Medicine LLC
13208 E. Shea Blvd., Suite 10
Scottsdale, Arizona, 85259
T 520-750-1488
F 866-513-6059
www.systems-medicine.com
Aequus BioPharma, Inc.
T 206-855-7802
F 206-201-7277
info@aequusbio.com
www.aequusbiopharma.com
Email inquiries by completing the Information Request form.
Investors and security analysts may also direct their inquiries to:
Ed Bell
Director, Investor Relations
T 206-272-4345
F 206-284-6206
invest@ctiseattle.com
Italian investors may contact our Italian office directly:
Elena Murador
T +39 02 61035 808
investors.italia@ctimilano.com
Transfer Agent
Shareholder inquiries on records/address changes, certificates, etc. should be directed to:
Computershare
T 312-588-4187
F 312-601-4332
www.computershare.com
Media should direct their inquiries to:
Dan Eramian
T 206-272-4343 (US)
T 800-215-CELL (US)
F 206-272-4010
DEramian@ctiseattle.com
Media@ctiseattle.com
Medical information and clinical trial inquiries on our products can be made by completing our Medical Information Request.
Unrestricted Education Grants
Healthcare professionals in the United States who are practicing in the hematology/oncology malignancy settings may apply for an unrestricted education grant. For information, click here.
If you are interested in employment with CTI, please check our Careers section.
If you have questions, comments or concerns about the functionality of this Web site, please direct your inquiries to our Webmaster.